University of Birmingham
Innova Medical Group Licenses Molecular Testing Tech From University of Birmingham
The RTF-EXPAR technology provides molecular detection in as little as 10 minutes without the requirement for reverse transcription.
University of Birmingham, Nonacus to Develop Urine Cancer Liquid Biopsy Assay
The partners plan to offer the assay, which uses Nonacus' liquid biopsy sample prep platform and a biomarker panel validated by the university, by mid-2022.
The firm said it believes that the results of a recent study are representative of the broader utility of the test and its potential for broad application to diagnose concussions.
Linear Diagnostics, which recently raised £800,000, is also seeking partners to help it market its test platform worldwide.
Linear Diagnostics Secures $1.1M to Develop Point-of-Care Diagnostics Platform
The firm said it is developing a rapid test for chlamydia and gonorrhea that will be able to detect multiple infections in the same sample in around 15 minutes.